my apologies I found the aug 2019 article on Revascor for End-Stage Heart Failure Patients with LVADs and the data was v encouraging but again the patient numbers are not huge in the US and it still needs to get to market. Also the use of Entresto which in my experience is extremely effective has revolutionized the treatment of severe CCF and may greatly reduce the no of patients ending up with end stage heart failure. Again I reiterate that fixing degenerate disc pathology has the massive potential
my apologies I found the aug 2019 article on Revascor for...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.010(0.92%) |
Mkt cap ! $1.235B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.10 | $1.06 | $2.544M | 2.376M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 12724 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 90680 | 25 |
View Market Depth
| Last trade - 13.03pm 20/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |